Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-24

Clinical Trial Update: A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler® [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing asthma control with Symbicort Turbuhaler alone versus in combination with Pulmicort Turbuhaler and Terbutaline Turbuhaler; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pulmicort Turbuhaler (budesonide)
  • Symbicort Turbuhaler (budesonide/formoterol)
  • Terbutaline Turbuhaler (terbutaline)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED